GOSSAMER BIO, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-5.7M | $-5.7M | — | $32.0K |
| FY2018 | $-51.0M | $-54.5M | $3.5M | $30.9M |
| FY2019 | $-144.8M | $-147.8M | $3.0M | $20.8M |
| FY2020 | $-176.4M | $-177.9M | $1.5M | $38.7M |
| FY2021 | $-188.9M | $-190.4M | $1.5M | $32.0M |
| FY2022 | $-187.0M | $-187.4M | $410.0K | $42.6M |
| FY2023 | $-159.2M | $-159.2M | $0 | $28.5M |
| FY2024 | $-3.5M | $-3.5M | $0 | $20.6M |
| FY2025 | $-171.3M | $-171.3M | $79.0K | $10.6M |